Farmsintez ao

Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.

LIFE | MOEX

Overview

Corporate Details

ISIN(s):: RU000A0JR514
LEI:
Country:: Russian Federation
Address:: Kuzmolovskii Gorodskoi Poselok, Stantsiya Kapitolovo 134, 188663 Leningrad Oblast
Website:: http://pharmsynthez.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Farmsintez ao is a pharmaceutical company specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily consists of prescription medicines for hospital use, targeting therapeutic areas such as oncology, infectious diseases, women's health, nephrology, and orphan diseases. The company operates a GMP-compliant scientific and production complex, which includes a high-tech facility for API synthesis and a research center focused on fine organic synthesis for new drug development. Farmsintez also provides contract manufacturing and pharmaceutical development services.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Farmsintez ao and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Farmsintez ao filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Farmsintez ao via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
2cureX AB Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.	Sweden	2CUREX
4BASEBIO PLC Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.	United Kingdom	4BB
4SC AG Developing small-molecule epigenetic drugs for high-need cancer indications.	Germany	VSC
Abera Bioscience AB Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.	Sweden	ABERA
ABINGDON HEALTH PLC A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.	United Kingdom	ABDX
ABIONYX Pharma Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.	France	ABNX
Abliva Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.	Sweden	ABLI
AB Science Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.	France	AB
Active Biotech Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.	Sweden	ACTI
AcuCort AB Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.	Sweden	ACUC